318
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Consumer Perceptions of Medication Warnings About Driving: A Comparison of French and Australian Labels

, , , &
Pages 557-564 | Received 26 Apr 2012, Accepted 06 Sep 2012, Published online: 16 Jul 2013
 

Abstract

Objective: Little research has examined user perceptions of medication warnings about driving. Consumer perceptions of the Australian national approach to medication warnings about driving are examined. The Australian approach to warning presentation is compared with an alternative approach used in France. Visual characteristics of the warnings and overall warning readability are investigated. Risk perceptions and behavioral intentions associated with the warnings are also examined.

Method: Surveys were conducted with 358 public hospital outpatients in Queensland, Australia. Extending this investigation is a supplementary comparison study of French hospital outpatients (n = 75).

Results: The results suggest that the Australian warning approach of using a combination of visual characteristics is important for consumers but that the use of a pictogram could enhance effects. Significantly higher levels of risk perception were found among the sample for the French highest severity label compared to the analogous mandatory Australian warning, with a similar trend evident in the French study results. The results also indicated that the French label was associated with more cautious behavioral intentions.

Conclusion: The results are potentially important for the Australian approach to medication warnings about driving impairment. The research contributes practical findings that can be used to enhance the effectiveness of warnings and develop countermeasures in this area. Hospital pharmacy patients should include persons with the highest level of likelihood of knowledge and awareness of medication warning labeling. Even in this context it appears that a review of the Australian warning system would be useful particularly in the context of increasing evidence relating to associated driving risks. Reviewing text size and readability of messages including the addition of pictograms, as well as clarifying the importance of potential risk in a general community context, is recommended for consideration and further research.

Acknowledgments

The authors acknowledge the funding provided by the NRMA-ACT Road Safety Trust Fund. The work has been prepared exclusively by the grant recipient and has not been endorsed and is not guaranteed by the trustees. The authors thank Patricia Watson and Claire Hickey of the QUT Pharmacy Department for their advice regarding pharmaceuticals and labeling, the staff and clients of the participating hospitals, and CARRS-Q staff, Hanna Thunstrom, Dominique Lynch and Melissa Bailey, for their assistance with data collection.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.